Jinfo: Product review of PharmaCircle Business Class Professional

Product review of PharmaCircle Business Class Professional
Jinfo Report

19th June 2017

Abstract

PharmaCircle's Business Class Professional is an online platform used by professionals in the biopharmaceutical industry and provides comprehensive product and business related information. The product is tailored towards business development professionals in smaller companies and offers a comprehensive view into drugs, biologics and combination product development and innovation worldwide. It offers a wide range of information sources and module search features as well as application searches, such as Prospector and Spyglass, which can be used to keep track of specific company news or product events.

This review:

Introduces the platform's key advantages
Looks at Business Class Professional's value and highlights the platform's broad range of information sources and modules
Explores the platform's technology, particularly its user-friendly search and user interactions
Looks at the outputs and the product administration
Identifies competitors, including Thomson Reuters' Cortellis, Informa's Pharmaprojects and GlobalData
Outlines development plans
Explains the pricing model
Explores the help and training available.

Reviewed by Dr. Michelle Maxwell

Content Access

Access to Jinfo Content and Community is available through a Jinfo Subscription.

Does your organisation have a Jinfo Subscription?

"Yes"

Please sign in to MyJinfo here so that we can check your access to this item:

Or sign in via email:

Enter your email and we'll send you a magic link to sign you in automatically.

"Not yet"

Access to this report is available through a Jinfo Subscription, which will help your organisation:

Save time and money
Re-invent information services
Define, measure and communicate information value.

"Don't know"

Contact us to find out if your organisation already has a Jinfo Subscription.

Or use the 'Text Chat' button at the bottom-right of this page for immediate assistance.

About this report